Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C031278 |
2-chloroethyl ethyl sulfide |
2-chloroethyl ethyl sulfide results in increased expression of ATF2 protein | increases expression | 18675330
|
C021296 |
2-ethoxyethanol |
2-ethoxyethanol results in increased expression of ATF2 mRNA | increases expression | 19643169
|
C090942 |
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole |
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [ATF2 protein results in decreased susceptibility to Cisplatin] | decreases reaction|decreases response to substance | 12663670
|
C090942 |
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole |
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Cisplatin results in increased activity of ATF2 protein] | decreases reaction|increases activity | 12663670
|
C090942 |
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole |
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Cisplatin results in increased phosphorylation of and results in increased activity of ATF2 protein] | decreases reaction|increases activity|increases phosphorylation | 12663670
|
C108123 |
4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine |
4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine inhibits the reaction [deoxynivalenol results in increased phosphorylation of ATF2 protein] | decreases reaction|increases phosphorylation | 15772366
|
D000111 |
Acetylcysteine |
Acetylcysteine inhibits the reaction [pyrrolidine dithiocarbamic acid results in increased phosphorylation of ATF2 protein] | decreases reaction|increases phosphorylation | 10661865
|
D000171 |
Acrolein |
[Acrolein results in increased phosphorylation of MAPK14 protein] which results in increased phosphorylation of ATF2 protein | increases phosphorylation | 12487375
|
D024502 |
alpha-Tocopherol |
alpha-Tocopherol inhibits the reaction [Tamoxifen results in increased phosphorylation of ATF2 protein] | decreases reaction|increases phosphorylation | 14645110
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of ATF2 mRNA | affects expression | 16483693
|
D000643 |
Ammonium Chloride |
Ammonium Chloride results in increased expression of ATF2 protein | increases expression | 16483693
|
D003913 |
Dextroamphetamine |
Dextroamphetamine results in increased expression of ATF2 mRNA | increases expression | 18305237
|
D000841 |
Anisomycin |
Anisomycin results in increased phosphorylation of ATF2 protein | increases phosphorylation | 12663670
|
C432165 |
anthra(1,9-cd)pyrazol-6(2H)-one |
anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [ATF2 protein results in decreased susceptibility to Cisplatin] | decreases reaction|decreases response to substance | 12663670
|
C432165 |
anthra(1,9-cd)pyrazol-6(2H)-one |
anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [Cisplatin results in increased activity of ATF2 protein] | decreases reaction|increases activity | 12663670
|
C432165 |
anthra(1,9-cd)pyrazol-6(2H)-one |
anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [Cisplatin results in increased phosphorylation of and results in increased activity of ATF2 protein] | decreases reaction|increases activity|increases phosphorylation | 12663670
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in increased expression of ATF2 mRNA | increases expression | 17879257
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ATF2 mRNA | decreases expression | 19150397
|
D002713 |
Chlorine |
[Ozone co-treated with Chlorine] results in decreased expression of ATF2 mRNA | affects cotreatment|decreases expression | 18636392
|
D003300 |
Copper |
Copper promotes the reaction [Disulfiram results in decreased activity of ATF2 protein] | decreases activity|increases reaction | 15367699
|
D003300 |
Copper |
[Disulfiram co-treated with Copper] results in decreased activity of ATF2 protein | affects cotreatment|decreases activity | 15367699
|
D003520 |
Cyclophosphamide |
Cyclophosphamide results in increased expression of ATF2 mRNA | increases expression | 11599041
|
D016572 |
Cyclosporine |
Cyclosporine results in increased expression of ATF2 mRNA | increases expression | 20106945
|
C007262 |
deoxynivalenol |
4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine inhibits the reaction [deoxynivalenol results in increased phosphorylation of ATF2 protein] | decreases reaction|increases phosphorylation | 15772366
|
C007262 |
deoxynivalenol |
deoxynivalenol affects the localization of ATF2 protein | affects localization | 12604842
|
C007262 |
deoxynivalenol |
deoxynivalenol results in increased phosphorylation of ATF2 protein | increases phosphorylation | 15772366
|
D002945 |
Cisplatin |
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [ATF2 protein results in decreased susceptibility to Cisplatin] | decreases reaction|decreases response to substance | 12663670
|
D002945 |
Cisplatin |
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Cisplatin results in increased activity of ATF2 protein] | decreases reaction|increases activity | 12663670
|
D002945 |
Cisplatin |
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Cisplatin results in increased phosphorylation of and results in increased activity of ATF2 protein] | decreases reaction|increases activity|increases phosphorylation | 12663670
|
D002945 |
Cisplatin |
anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [ATF2 protein results in decreased susceptibility to Cisplatin] | decreases reaction|decreases response to substance | 12663670
|
D002945 |
Cisplatin |
anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [Cisplatin results in increased activity of ATF2 protein] | decreases reaction|increases activity | 12663670
|
D002945 |
Cisplatin |
anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [Cisplatin results in increased phosphorylation of and results in increased activity of ATF2 protein] | decreases reaction|increases activity|increases phosphorylation | 12663670
|
D002945 |
Cisplatin |
ATF2 protein results in decreased susceptibility to Cisplatin | decreases response to substance | 12663670
|
D002945 |
Cisplatin |
Cisplatin results in increased phosphorylation of and results in increased activity of ATF2 protein | increases activity|increases phosphorylation | 12663670
|
D002945 |
Cisplatin |
Cisplatin results in increased phosphorylation of ATF2 protein | increases phosphorylation | 15701814
|
D004052 |
Diethylnitrosamine |
[Diethylnitrosamine co-treated with Piperonyl Butoxide] results in increased expression of ATF2 mRNA | affects cotreatment|increases expression | 19690152
|
D004221 |
Disulfiram |
Copper promotes the reaction [Disulfiram results in decreased activity of ATF2 protein] | decreases activity|increases reaction | 15367699
|
D004221 |
Disulfiram |
[Disulfiram co-treated with Copper] results in decreased activity of ATF2 protein | affects cotreatment|decreases activity | 15367699
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol affects the expression of ATF2 mRNA | affects expression | 17555576
|
D005047 |
Etoposide |
Etoposide results in increased phosphorylation of and results in increased activity of ATF2 protein | increases activity|increases phosphorylation | 12663670
|
C007845 |
gingerol |
gingerol inhibits the reaction [TNF protein results in increased phosphorylation of ATF2 protein] | decreases reaction|increases phosphorylation | 18577375
|
D008094 |
Lithium |
[Lithium co-treated with Pilocarpine] results in decreased expression of ATF2 protein | affects cotreatment|decreases expression | 19430551
|
C081145 |
methionylmethylsulfonium chloride |
methionylmethylsulfonium chloride results in increased phosphorylation of and results in increased activity of ATF2 protein | increases activity|increases phosphorylation | 12663670
|
C005219 |
methyl cellosolve |
methyl cellosolve results in increased expression of ATF2 mRNA | increases expression | 19643169
|
C008493 |
methylselenic acid |
methylselenic acid results in increased phosphorylation of and results in increased activity of ATF2 protein | increases activity|increases phosphorylation | 11830524
|
D009151 |
Mustard Gas |
Mustard Gas results in increased phosphorylation of ATF2 protein | increases phosphorylation | 18200059
|
D009151 |
Mustard Gas |
Mustard Gas affects the expression of ATF2 mRNA | affects expression | 18988085
|
D010126 |
Ozone |
[Ozone co-treated with Chlorine] results in decreased expression of ATF2 mRNA | affects cotreatment|decreases expression | 18636392
|
C023036 |
perfluorooctanoic acid |
perfluorooctanoic acid results in increased expression of ATF2 mRNA | increases expression | 17560707
|
D010862 |
Pilocarpine |
[Lithium co-treated with Pilocarpine] results in decreased expression of ATF2 protein | affects cotreatment|decreases expression | 19430551
|
C008922 |
piperine |
piperine results in decreased localization of ATF2 protein | decreases localization | 15531295
|
D010882 |
Piperonyl Butoxide |
[Diethylnitrosamine co-treated with Piperonyl Butoxide] results in increased expression of ATF2 mRNA | affects cotreatment|increases expression | 19690152
|
D010882 |
Piperonyl Butoxide |
Piperonyl Butoxide results in increased expression of ATF2 mRNA | increases expression | 19690152
|
D010882 |
Piperonyl Butoxide |
Piperonyl Butoxide results in increased phosphorylation of ATF2 protein | increases phosphorylation | 18228000
|
C526689 |
punarnavine |
punarnavine results in decreased localization of ATF2 protein | decreases localization | 20192578
|
C020972 |
pyrrolidine dithiocarbamic acid |
Acetylcysteine inhibits the reaction [pyrrolidine dithiocarbamic acid results in increased phosphorylation of ATF2 protein] | decreases reaction|increases phosphorylation | 10661865
|
C020972 |
pyrrolidine dithiocarbamic acid |
pyrrolidine dithiocarbamic acid results in increased phosphorylation of ATF2 protein | increases phosphorylation | 10661865
|
D012645 |
Selenomethionine |
Selenomethionine affects the expression of ATF2 mRNA | affects expression | 17222674
|
C017947 |
sodium arsenite |
sodium arsenite results in increased activity of ATF2 protein | increases activity | 15292961 12220541
|
C017947 |
sodium arsenite |
sodium arsenite results in increased expression of ATF2 mRNA | increases expression | 17879257 12016162
|
D013629 |
Tamoxifen |
alpha-Tocopherol inhibits the reaction [Tamoxifen results in increased phosphorylation of ATF2 protein] | decreases reaction|increases phosphorylation | 14645110
|
D013629 |
Tamoxifen |
Tamoxifen results in increased phosphorylation of ATF2 protein | increases phosphorylation | 14645110
|
D013629 |
Tamoxifen |
Tamoxifen affects the expression of ATF2 mRNA | affects expression | 17555576
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of ATF2 mRNA | increases expression | 15251184
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of ATF2 mRNA | increases expression | 15897893
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased phosphorylation of ATF2 protein | increases phosphorylation | 15897893
|
D014212 |
Tretinoin |
Tretinoin affects the localization of ATF2 protein | affects localization | 16511568
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
4.11 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
2-ethoxyethanol |
16.98 | 6499812 6499823 6499820 6499796 7151721 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Disulfiram |
16.98 | 17676605 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
methyl cellosolve |
16.98 | 3652986 6474471 6499812 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
16.98 | 14514962 15322242 11752688 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.13 | 18287403 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.50 | 17505938 |
MESH:D000163 |
Acquired Immunodeficiency Syndrome |
|
Disulfiram |
5.13 | 9207937 |
MESH:D058186 |
Acute Kidney Injury |
|
Cisplatin |
3.58 | 15814532 17670903 12690470 |
MESH:D055371 |
Acute Lung Injury |
|
Acrolein |
8.42 | 20525806 21297076 |
MESH:D055371 |
Acute Lung Injury |
|
Chlorine |
8.42 | 20601635 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
6.35 | 20127859 20464547 |
MESH:D000230 |
Adenocarcinoma |
|
Cisplatin |
6.35 | 17638652 11798837 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
6.35 | 14692618 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
5.77 | 6695378 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
5.77 | 6695378 10737359 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
8.62 | 16434500 17620307 18056438 19052882 17162532 19061943 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
8.62 | 16835633 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.26 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.46 | 17306315 16712894 |
MESH:D000437 |
Alcoholism |
|
Disulfiram |
4.64 | 18968458 10841824 17079463 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.27 | 15955085 |
MESH:D000544 |
Alzheimer Disease |
|
Acrolein |
8.63 | 14715435 17570602 15207723 |
MESH:D000544 |
Alzheimer Disease |
|
Copper |
8.63 | 17119284 16866297 16886094 16962711 16325427 16410023 |
MESH:D000544 |
Alzheimer Disease |
|
Lithium |
8.63 | 19621015 |
MESH:D000544 |
Alzheimer Disease |
|
Ozone |
8.63 | 15513908 |
MESH:D000690 |
Amyotrophic Lateral Sclerosis |
|
Copper |
4.02 | 10694572 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.58 | 11748828 |
MESH:D018798 |
Anemia, Iron-Deficiency |
|
Copper |
4.50 | 16614410 |
MESH:D000748 |
Anemia, Macrocytic |
|
methyl cellosolve |
5.91 | 3699323 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
3.65 | 19183758 |
MESH:D001161 |
Arteriosclerosis |
|
Acrolein |
14.78 | 15014928 |
MESH:D001161 |
Arteriosclerosis |
|
Cyclophosphamide |
14.78 | 15014928 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
14.78 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
6.30 | 15885639 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
6.30 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Ozone |
4.27 | 15570426 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
4.27 | 16292516 |
MESH:D053627 |
Asthenozoospermia |
|
2-ethoxyethanol |
11.17 | 10689203 6499807 6499823 |
MESH:D053627 |
Asthenozoospermia |
|
methyl cellosolve |
11.17 | 3987992 |
MESH:D001249 |
Asthma |
|
Mustard Gas |
7.08 | 10378619 |
MESH:D001249 |
Asthma |
|
Ozone |
7.08 | 17854713 16373670 |
MESH:D001249 |
Asthma |
|
Tretinoin |
7.08 | 16456186 |
MESH:D001259 |
Ataxia |
|
2-ethoxyethanol |
5.06 | 7151721 |
MESH:D050197 |
Atherosclerosis |
|
Acrolein |
3.72 | 16126721 17363696 16037261 |
MESH:D001284 |
Atrophy |
|
2-ethoxyethanol |
10.05 | 6499799 15850284 |
MESH:D001284 |
Atrophy |
|
methyl cellosolve |
10.05 | 2626667 6705890 3699323 |
MESH:D053713 |
Azoospermia |
|
2-ethoxyethanol |
5.16 | 6499807 6492198 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
3.99 | 16935849 |
MESH:D001714 |
Bipolar Disorder |
|
Lithium |
4.09 | 20338123 17594078 19153942 20046352 |
MESH:D001724 |
Birth Weight |
|
2-ethoxyethanol |
6.07 | 2884743 6499823 |
MESH:D001768 |
Blister |
|
Mustard Gas |
4.73 | 19167455 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
7.66 | 12125929 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
7.66 | 16206674 16197459 |
MESH:D001836 |
Body Weight Changes |
|
2-ethoxyethanol |
10.56 | 6499796 7151721 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
10.56 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.48 | 15746008 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Cisplatin |
10.76 | 14601052 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Etoposide |
10.76 | 14601052 |
MESH:D001932 |
Brain Neoplasms |
|
Copper |
4.18 | 17079463 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
7.66 | 17474063 20146248 |
MESH:D001943 |
Breast Neoplasms |
|
Cisplatin |
7.66 | 19526202 18382427 |
MESH:D001943 |
Breast Neoplasms |
|
Copper |
7.66 | 15986119 17079463 |
MESH:D001943 |
Breast Neoplasms |
|
Cyclophosphamide |
7.66 | 11325840 18234424 18323546 17388661 12006526 17020986 15093573 15136595 16978400 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
7.66 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Disulfiram |
7.66 | 17026967 |
MESH:D001943 |
Breast Neoplasms |
|
Etoposide |
7.66 | 16322251 |
MESH:D001943 |
Breast Neoplasms |
|
gingerol |
7.66 | 17683926 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
7.66 | 18984771 19289846 17242785 20544844 19244106 20390343 19155303 17440819 11161223 21138602 20135344 17261762 20005174 19103187 19066611 15668708 19059307 19487384 18997820 16873071 16818667 19115204 20065188 19200415 16273361 15565566 18821012 20859285 19011961 19288272 19221464 19410462 18855134 17049068 17893378 18425577 18815881 21152245 18629630 19142967 18351453 19189210 19189212 16202921 19084267 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
7.66 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
7.66 | 16166294 16443354 16873071 |
MESH:D016535 |
Bronchial Hyperreactivity |
|
Ozone |
3.34 | 16777450 18315731 15516495 19059883 18417511 14754758 17626835 |
MESH:D001989 |
Bronchiolitis Obliterans |
|
Mustard Gas |
4.73 | 15286001 |
MESH:D029481 |
Bronchitis, Chronic |
|
Mustard Gas |
4.54 | 17687719 10378619 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.16 | 16813970 |
MESH:D002100 |
Cachexia |
|
Ozone |
4.31 | 16183385 |
MESH:D002177 |
Candidiasis |
|
Disulfiram |
5.42 | 15325261 |
MESH:D002277 |
Carcinoma |
|
Disulfiram |
7.50 | 17026967 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
7.50 | 16835633 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.08 | 19066611 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
4.72 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
anthra(1,9-cd)pyrazol-6(2H)-one |
12.79 | 19418558 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Cisplatin |
12.79 | 17982673 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Cyclophosphamide |
12.79 | 19701751 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
12.79 | 17761372 18978308 17138121 11831363 19539802 20524982 19335982 16698587 20007298 17428255 17173139 16540662 19822196 16830150 16288022 20432363 19701751 18494052 16779866 18785209 21159647 20935162 3581430 16807293 18506893 19519916 19171122 20084675 17978847 19394651 19919837 19418558 10737359 18691550 10672840 20101231 16502159 19052882 17162532 19107877 16681979 20514400 20727157 20214788 19383236 18788625 16878318 16935385 20512989 17055752 18210153 3084413 16328049 18665156 18393292 18056438 18971187 16569478 19208518 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
12.79 | 17306315 15276417 16507464 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
12.79 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
12.79 | 1917145 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
Cyclophosphamide |
4.46 | 16152834 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
Cisplatin |
5.57 | 12023789 16685392 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
Disulfiram |
5.57 | 17026967 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Cyclophosphamide |
3.33 | 16201981 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Acetylcysteine |
12.82 | 17015178 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
12.82 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Cisplatin |
12.82 | 6189445 18337622 17066447 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
12.82 | 18572023 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
12.82 | 16051514 16096774 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
3.24 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Copper |
6.23 | 17327471 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
6.23 | 18850075 18670907 16120746 |
MESH:D002386 |
Cataract |
|
Disulfiram |
7.06 | 15003327 17936468 |
MESH:D002386 |
Cataract |
|
Tretinoin |
7.06 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
17.92 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Acetylcysteine |
17.92 | 18226522 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
17.92 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
17.92 | 17174075 2727394 21159647 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
17.92 | 20056578 19524636 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.16 | 16129372 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
8.12 | 19052882 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
8.12 | 16835633 |
MESH:D002764 |
Cholecystitis |
|
2-ethoxyethanol |
12.19 | 6499794 |
MESH:D002764 |
Cholecystitis |
|
methyl cellosolve |
12.19 | 6499794 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
6.71 | 19486331 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
6.71 | 17333356 17110522 15861022 17681005 16919318 11677210 16105132 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
4.72 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
5.12 | 16354765 15340226 12621046 8697196 15668235 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
5.12 | 9407595 |
MESH:D019970 |
Cocaine-Related Disorders |
|
Disulfiram |
5.31 | 19462300 |
MESH:D003092 |
Colitis |
|
Tretinoin |
3.29 | 17035595 |
MESH:D015179 |
Colorectal Neoplasms |
|
Acrolein |
2.94 | 17597105 |
MESH:D015179 |
Colorectal Neoplasms |
|
Cisplatin |
2.94 | 15273666 |
MESH:D000013 |
Congenital Abnormalities |
|
methyl cellosolve |
8.22 | 6499821 12530607 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
8.22 | 14669216 17141729 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.29 | 20055451 15322242 10048152 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
2.29 | 16925845 14991402 9142499 9125849 9211117 9664655 9224671 10589399 8800419 17551590 |
MESH:D003550 |
Cystic Fibrosis |
|
Acetylcysteine |
4.01 | 19747007 |
MESH:D003556 |
Cystitis |
|
Acrolein |
10.62 | 12161096 |
MESH:D003556 |
Cystitis |
|
Cyclophosphamide |
10.62 | 16614059 18710439 18093676 16651033 15643279 10700343 10498854 17010015 18433785 12161096 12913760 16989017 15276878 12388444 18295254 11948286 18372110 18483878 17979934 16413132 |
MESH:D007644 |
Darier Disease |
|
Lithium |
5.48 | 20338123 |
MESH:D003643 |
Death |
|
2-ethoxyethanol |
5.52 | 6499796 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
3.94 | 19031437 |
MESH:D018500 |
Diabetes Insipidus, Nephrogenic |
|
Lithium |
5.32 | 19244398 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Cyclophosphamide |
3.72 | 11751995 10990075 15331540 |
MESH:D003922 |
Diabetes Mellitus, Type 1 |
|
Cyclophosphamide |
3.08 | 18772604 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
alpha-Tocopherol |
6.55 | 16506275 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
6.55 | 20387270 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
6.55 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
3.12 | 19279558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetylcysteine |
5.49 | 11287661 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
5.49 | 19107877 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
5.49 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Cisplatin |
7.11 | 12231392 19839026 15033597 12649298 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
7.11 | 11462148 |
MESH:D004417 |
Dyspnea |
|
Chlorine |
4.19 | 20016425 |
MESH:D004487 |
Edema |
|
Mustard Gas |
9.37 | 11428631 11428647 9260866 11402378 |
MESH:D004487 |
Edema |
|
perfluorooctanoic acid |
9.37 | 17259670 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
9.37 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
10.48 | 18230668 15322242 16714409 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
10.48 | 18230668 |
MESH:D020964 |
Embryo Loss |
|
2-ethoxyethanol |
6.07 | 6499796 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
7.59 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
7.59 | 19031437 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
6.48 | 17893378 19155303 20544844 16202921 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
6.48 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.65 | 9294722 10568697 |
MESH:D004802 |
Eosinophilia |
|
Cyclophosphamide |
3.80 | 11006010 |
MESH:D004827 |
Epilepsy |
|
Pilocarpine |
4.42 | 19700373 11162239 19439326 |
MESH:D004890 |
Erythema |
|
Mustard Gas |
4.73 | 9357497 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
4.68 | 16302075 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
6.52 | 20426865 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
6.52 | 16530937 |
MESH:D004938 |
Esophageal Neoplasms |
|
Cisplatin |
6.52 | 15173087 16481741 17638652 16785472 15464296 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
7.76 | 11564622 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
7.76 | 9664655 16938888 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
15.60 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
15.60 | 21071580 20387270 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
15.60 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
15.60 | 14986274 19224547 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
2.97 | 16709447 |
MESH:D005313 |
Fetal Death |
|
2-ethoxyethanol |
9.44 | 2884743 7198755 6499823 7151721 6499820 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
9.44 | 11858732 |
MESH:D005317 |
Fetal Growth Retardation |
|
2-ethoxyethanol |
5.00 | 6499796 |
MESH:D005327 |
Fetal Resorption |
|
2-ethoxyethanol |
11.21 | 6499820 6499812 |
MESH:D005327 |
Fetal Resorption |
|
methyl cellosolve |
11.21 | 6499821 6474471 3987992 6499812 |
MESH:D020567 |
Fetal Weight |
|
2-ethoxyethanol |
12.19 | 7151721 2884743 6499820 |
MESH:D020567 |
Fetal Weight |
|
methyl cellosolve |
12.19 | 6499821 6474471 6499812 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.10 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
3.75 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
12.29 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
12.29 | 20067830 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
12.29 | 17994277 |
MESH:D005532 |
Foot Deformities, Congenital |
|
methyl cellosolve |
5.07 | 3652986 |
MESH:D005739 |
Gas Poisoning |
|
Chlorine |
4.57 | 20016425 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.25 | 16452187 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
3.79 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
2.72 | 17312396 |
MESH:D018316 |
Gliosarcoma |
|
Cyclophosphamide |
5.08 | 11389073 |
MESH:D005922 |
Glomerulonephritis, IGA |
|
deoxynivalenol |
4.67 | 15173396 16524712 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.15 | 10696789 |
MESH:D006086 |
Graft vs Host Disease |
|
Cyclophosphamide |
4.61 | 11014644 16376943 15172196 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Cisplatin |
6.93 | 15464296 15102660 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
6.93 | 16096774 |
MESH:D034381 |
Hearing Loss |
|
Cisplatin |
3.93 | 19898482 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
4.72 | 16084493 |
MESH:D006319 |
Hearing Loss, Sensorineural |
|
Cisplatin |
4.07 | 15464296 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
14.07 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Lithium |
14.07 | 19638421 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
14.07 | 10048152 11294989 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
14.07 | 14991402 9664655 |
MESH:D006345 |
Heart Septal Defects, Ventricular |
|
methyl cellosolve |
5.35 | 6499821 |
MESH:D006402 |
Hematologic Diseases |
|
2-ethoxyethanol |
4.99 | 10514026 20172899 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
3.99 | 15720958 |
MESH:D006461 |
Hemolysis |
|
2-ethoxyethanol |
10.88 | 17874071 19051582 |
MESH:D006461 |
Hemolysis |
|
methyl cellosolve |
10.88 | 17874071 |
MESH:D006467 |
Hemophilia A |
|
Cyclophosphamide |
4.87 | 11918545 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
2.95 | 11000095 |
MESH:D006504 |
Hepatic Veno-Occlusive Disease |
|
Cyclophosphamide |
5.09 | 14986274 |
MESH:D006521 |
Hepatitis, Chronic |
|
Copper |
4.84 | 17338147 |
MESH:D006527 |
Hepatolenticular Degeneration |
|
Copper |
4.75 | 16607473 17109627 19888908 17182432 17276780 |
MESH:D006529 |
Hepatomegaly |
|
perfluorooctanoic acid |
7.28 | 3609246 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
7.28 | 12621046 15340226 16120746 |
MESH:D006561 |
Herpes Simplex |
|
Etoposide |
4.13 | 10809021 |
MESH:D006689 |
Hodgkin Disease |
|
Cisplatin |
14.59 | 16200630 16170182 |
MESH:D006689 |
Hodgkin Disease |
|
Cyclophosphamide |
14.59 | 17606976 16135485 |
MESH:D006689 |
Hodgkin Disease |
|
Etoposide |
14.59 | 16135485 18180244 17606976 16200630 15147373 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
14.59 | 12676792 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.61 | 16354765 15340226 16959395 8697196 18606429 |
MESH:D006930 |
Hyperalgesia |
|
perfluorooctanoic acid |
6.92 | 12083418 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
6.92 | 16870215 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.15 | 16778211 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
4.35 | 10903974 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
4.35 | 18670907 18850075 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.39 | 16945680 16569931 |
MESH:D007154 |
Immune System Diseases |
|
Cyclophosphamide |
4.89 | 16076520 |
MESH:D007247 |
Infertility, Female |
|
2-ethoxyethanol |
9.08 | 6499823 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
9.08 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
2-ethoxyethanol |
18.06 | 6499823 |
MESH:D007248 |
Infertility, Male |
|
Cyclophosphamide |
18.06 | 16517039 7193160 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
18.06 | 17937319 |
MESH:D007248 |
Infertility, Male |
|
methyl cellosolve |
18.06 | 3987992 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
18.06 | 12646999 15346721 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
13.36 | 18785209 |
MESH:D007249 |
Inflammation |
|
Mustard Gas |
13.36 | 9260866 16001271 11428631 11428647 11428620 11402378 17524151 9357497 8975870 |
MESH:D007249 |
Inflammation |
|
perfluorooctanoic acid |
13.36 | 12083418 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
13.36 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
13.36 | 12200463 12878042 |
MESH:D007251 |
Influenza, Human |
|
pyrrolidine dithiocarbamic acid |
5.12 | 18473937 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.35 | 17994277 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
8.65 | 16580747 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
8.65 | 17551590 15992940 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.00 | 15604871 |
MESH:D007673 |
Kidney Cortex Necrosis |
|
Cisplatin |
4.70 | 15464296 |
MESH:D007674 |
Kidney Diseases |
|
Acrolein |
12.41 | 12488133 |
MESH:D007674 |
Kidney Diseases |
|
Cisplatin |
12.41 | 18289764 15190930 12231392 12649298 19839026 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
12.41 | 8314463 10903974 18776723 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
12.41 | 20008137 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Copper |
4.51 | 16518626 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
6.14 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
6.14 | 18625569 |
MESH:D007683 |
Kidney Tubular Necrosis, Acute |
|
Cisplatin |
4.36 | 11231351 |
MESH:D007859 |
Learning Disorders |
|
Copper |
4.38 | 17134702 |
MESH:D007938 |
Leukemia |
|
Cyclophosphamide |
5.83 | 10602166 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
5.83 | 17143497 |
MESH:D015451 |
Leukemia, Lymphocytic, Chronic, B-Cell |
|
Cyclophosphamide |
6.47 | 17802794 18172266 17008537 17296974 17658394 18587576 |
MESH:D015451 |
Leukemia, Lymphocytic, Chronic, B-Cell |
|
Disulfiram |
6.47 | 17026967 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
anthra(1,9-cd)pyrazol-6(2H)-one |
4.94 | 16972261 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
Cyclophosphamide |
3.77 | 10373061 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
3.32 | 19285840 16482212 16932348 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
2.00 | 17596541 16294345 19850784 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
2.87 | 17301526 19642359 17361223 19075265 16140955 17712046 17294898 17107899 19029980 16788101 19225113 17339181 16823087 19035177 17649720 16331271 12679006 17368321 17506722 15748426 16935935 9834237 16891316 16766008 17217047 |
MESH:D007970 |
Leukopenia |
|
Cyclophosphamide |
4.53 | 10052129 11830472 |
MESH:D007984 |
Leydig Cell Tumor |
|
perfluorooctanoic acid |
4.80 | 8812269 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Disulfiram |
12.17 | 17676605 |
MESH:D017880 |
Limb Deformities, Congenital |
|
methyl cellosolve |
12.17 | 6499821 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
12.17 | 9224671 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
2.85 | 15342952 17567588 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
2.58 | 18522880 18407596 18665156 19638242 20032147 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pyrrolidine dithiocarbamic acid |
4.50 | 15078482 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
4.50 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
4.50 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
4.50 | 16248980 18397230 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
1.99 | 17034775 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
22.79 | 21137059 20195826 |
MESH:D008113 |
Liver Neoplasms |
|
Copper |
22.79 | 20302851 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
22.79 | 2862719 20434301 20583210 19254457 9163691 18644402 19996281 20501860 19833225 19090486 19255062 15885732 19256749 20118626 19642983 18978307 20405173 19294768 21167192 18648771 21071580 19551842 20492335 20101389 10737359 18977376 19812893 19850985 19499222 2422723 12112319 15175105 21047994 20452335 12771043 18754104 21278145 16942905 19073162 19638242 20137499 19427195 19690152 19426721 |
MESH:D008113 |
Liver Neoplasms |
|
perfluorooctanoic acid |
22.79 | 14757943 18709148 |
MESH:D008113 |
Liver Neoplasms |
|
Piperonyl Butoxide |
22.79 | 15890375 19690152 18648771 20101389 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
22.79 | 16712894 15276417 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
22.79 | 16684651 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
22.79 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
4.86 | 19126423 19539802 18544905 2563599 3124819 16267830 18164116 21159647 16842330 17174075 9362446 17854601 18253720 19009564 18093689 18079962 18282651 19004024 19519916 18775883 18308698 17942915 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
4.86 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
2-chloroethyl ethyl sulfide |
24.98 | 12815614 18675330 16252256 |
MESH:D008171 |
Lung Diseases |
|
Acetylcysteine |
24.98 | 12815614 |
MESH:D008171 |
Lung Diseases |
|
Acrolein |
24.98 | 11504702 |
MESH:D008171 |
Lung Diseases |
|
Mustard Gas |
24.98 | 18161513 18702808 |
MESH:D008171 |
Lung Diseases |
|
Ozone |
24.98 | 8266340 19066396 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
24.98 | 19095001 |
MESH:D055370 |
Lung Injury |
|
Ozone |
8.21 | 20417186 |
MESH:D055370 |
Lung Injury |
|
pyrrolidine dithiocarbamic acid |
8.21 | 16129981 |
MESH:D008175 |
Lung Neoplasms |
|
alpha-Tocopherol |
14.10 | 16401635 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
14.10 | 20064080 17053015 20135361 18520028 18569708 20464547 6695378 20869020 18816296 |
MESH:D008175 |
Lung Neoplasms |
|
Cisplatin |
14.10 | 17225452 6189445 11798837 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
14.10 | 20970405 6695378 21163286 20512841 |
MESH:D008175 |
Lung Neoplasms |
|
Mustard Gas |
14.10 | 8781369 3148597 |
MESH:D008175 |
Lung Neoplasms |
|
Ozone |
14.10 | 7614698 8597069 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
14.10 | 15276417 19931552 17306315 16712894 17077188 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
14.10 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
14.10 | 19555203 11884234 |
MESH:D008223 |
Lymphoma |
|
Cyclophosphamide |
7.02 | 12854902 |
MESH:D008223 |
Lymphoma |
|
Etoposide |
7.02 | 12556972 12854902 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Cyclophosphamide |
4.20 | 16675587 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Cyclophosphamide |
3.82 | 11911406 |
MESH:D008231 |
Lymphopenia |
|
methyl cellosolve |
5.35 | 3699323 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
3.33 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
2.35 | 11731420 19196722 14580682 16827153 19196723 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
4.11 | 19453300 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.60 | 17453147 |
MESH:D008545 |
Melanoma |
|
Cisplatin |
8.83 | 18505091 15577323 16432458 18332650 17023156 18176117 16809738 12883367 17761969 12393984 11135225 16248763 12374674 |
MESH:D008545 |
Melanoma |
|
Disulfiram |
8.83 | 15367699 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
8.83 | 16487513 19082730 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
8.83 | 12393984 19393235 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
8.83 | 16752155 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Cisplatin |
10.07 | 15990972 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
10.07 | 15990972 |
MESH:D008546 |
Melanoma, Experimental |
|
Acrolein |
10.04 | 10803710 |
MESH:D008546 |
Melanoma, Experimental |
|
Cyclophosphamide |
10.04 | 16388313 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.00 | 16940565 |
MESH:D007706 |
Menkes Kinky Hair Syndrome |
|
Copper |
5.45 | 17268249 17109627 |
MESH:D008654 |
Mesothelioma |
|
Cisplatin |
3.06 | 17638057 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.35 | 16801185 |
MESH:D008679 |
Metaplasia |
|
Ozone |
4.67 | 10496685 |
MESH:D009041 |
Motion Sickness |
|
Dextroamphetamine |
5.08 | 1613127 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
2.86 | 16381670 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
2.83 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
alpha-Tocopherol |
6.16 | 19595682 |
MESH:D009203 |
Myocardial Infarction |
|
Lithium |
6.16 | 16288908 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.68 | 12213967 |
MESH:D009336 |
Necrosis |
|
2-ethoxyethanol |
4.91 | 20172899 |
MESH:D009361 |
Neoplasm Invasiveness |
|
Disulfiram |
4.90 | 18047805 |
MESH:D009362 |
Neoplasm Metastasis |
|
Acetylcysteine |
16.01 | 14720322 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
16.01 | 3581430 9029167 |
MESH:D009362 |
Neoplasm Metastasis |
|
Disulfiram |
16.01 | 15367699 |
MESH:D009362 |
Neoplasm Metastasis |
|
punarnavine |
16.01 | 19171408 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
16.01 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.36 | 19410462 |
MESH:D009369 |
Neoplasms |
|
Acrolein |
20.58 | 17329238 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
20.58 | 11141357 |
MESH:D009369 |
Neoplasms |
|
Cisplatin |
20.58 | 16773208 |
MESH:D009369 |
Neoplasms |
|
Cyclophosphamide |
20.58 | 18854779 |
MESH:D009369 |
Neoplasms |
|
Disulfiram |
20.58 | 17079463 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
20.58 | 11559025 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
20.58 | 16594593 16946489 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
3.25 | 20056578 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
3.56 | 19196722 19200415 19189210 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Copper |
9.48 | 17308104 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Disulfiram |
9.48 | 15367699 |
MESH:D009393 |
Nephritis |
|
Acrolein |
5.85 | 12653641 |
MESH:D009395 |
Nephritis, Interstitial |
|
Cisplatin |
4.06 | 15464296 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.00 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
2.92 | 19348381 18481113 |
MESH:D009421 |
Nervous System Malformations |
|
Pilocarpine |
14.22 | 15987249 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
14.22 | 14600291 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
14.22 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
Acetylcysteine |
10.62 | 19446573 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
10.62 | 12854658 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
10.62 | 9142499 |
MESH:D009447 |
Neuroblastoma |
|
Cisplatin |
6.51 | 8761367 |
MESH:D009447 |
Neuroblastoma |
|
Cyclophosphamide |
6.51 | 15176712 8761367 16115947 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acrolein |
7.62 | 11342003 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
7.62 | 20387270 |
MESH:D017599 |
Neuroectodermal Tumors |
|
Cisplatin |
10.09 | 8761367 |
MESH:D017599 |
Neuroectodermal Tumors |
|
Cyclophosphamide |
10.09 | 12837982 8761367 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
4.68 | 20387270 |
MESH:D020258 |
Neurotoxicity Syndromes |
|
Disulfiram |
4.35 | 11005259 |
MESH:D009503 |
Neutropenia |
|
Cyclophosphamide |
8.21 | 8291058 |
MESH:D009503 |
Neutropenia |
|
Mustard Gas |
8.21 | 7688884 16761898 |
MESH:D052556 |
Niemann-Pick Disease, Type C |
|
perfluorooctanoic acid |
4.53 | 9802331 |
MESH:D009765 |
Obesity |
|
2-chloroethyl ethyl sulfide |
3.71 | 16289378 |
MESH:D009845 |
Oligospermia |
|
2-ethoxyethanol |
15.66 | 20172899 |
MESH:D009845 |
Oligospermia |
|
Cyclophosphamide |
15.66 | 16517039 |
MESH:D009845 |
Oligospermia |
|
methyl cellosolve |
15.66 | 3987992 |
MESH:D012516 |
Osteosarcoma |
|
Disulfiram |
4.83 | 18047805 |
MESH:D010051 |
Ovarian Neoplasms |
|
Cisplatin |
10.12 | 17225452 6897625 15464296 19769630 |
MESH:D010051 |
Ovarian Neoplasms |
|
Disulfiram |
10.12 | 17026967 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
10.12 | 15276417 17306315 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
10.12 | 16936753 |
MESH:D010146 |
Pain |
|
Cyclophosphamide |
5.90 | 18093676 12161096 |
MESH:D010146 |
Pain |
|
Tretinoin |
5.90 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Cisplatin |
14.52 | 19003803 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Cyclophosphamide |
14.52 | 11332152 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
14.52 | 16540662 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Etoposide |
14.52 | 19003803 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
14.52 | 15976015 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.29 | 11578682 |
MESH:D010300 |
Parkinson Disease |
|
Acrolein |
3.42 | 17690948 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
3.81 | 12520081 |
MESH:D010523 |
Peripheral Nervous System Diseases |
|
Cisplatin |
3.90 | 15464296 |
MESH:D010538 |
Peritonitis |
|
Ozone |
3.71 | 16369182 |
MESH:D010787 |
Photosensitivity Disorders |
|
Acrolein |
5.30 | 11550810 |
MESH:D010997 |
Pleural Neoplasms |
|
Cisplatin |
4.90 | 17638057 |
MESH:D011014 |
Pneumonia |
|
Ozone |
3.96 | 18007984 18929643 18381685 |
MESH:D011041 |
Poisoning |
|
Mustard Gas |
3.41 | 15727166 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.15 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
7.74 | 12371664 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
7.74 | 2563599 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Cyclophosphamide |
3.56 | 21297632 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
2-ethoxyethanol |
19.84 | 7198755 6499817 2884743 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
methyl cellosolve |
19.84 | 6499817 7974496 12530607 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
perfluorooctanoic acid |
19.84 | 17132714 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
19.84 | 11896295 11118676 11222880 11399792 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
2.77 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
Copper |
2.77 | 17308104 17079463 |
MESH:D011471 |
Prostatic Neoplasms |
|
Cyclophosphamide |
2.77 | 17136230 |
MESH:D011471 |
Prostatic Neoplasms |
|
Disulfiram |
2.77 | 19789329 |
MESH:D011471 |
Prostatic Neoplasms |
|
Etoposide |
2.77 | 17172428 |
MESH:D011471 |
Prostatic Neoplasms |
|
methylselenic acid |
2.77 | 16205645 |
MESH:D011471 |
Prostatic Neoplasms |
|
pyrrolidine dithiocarbamic acid |
2.77 | 16139439 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
2.77 | 16039940 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
2.77 | 15067354 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.21 | 16636307 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
8.10 | 15861022 16919318 |
MESH:D011537 |
Pruritus |
|
Mustard Gas |
8.10 | 18058305 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.07 | 16882103 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.36 | 16723453 |
MESH:D011657 |
Pulmonary Eosinophilia |
|
alpha-Tocopherol |
5.55 | 14606601 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Cyclophosphamide |
5.40 | 16636934 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Mustard Gas |
5.40 | 17894541 10334151 17720292 17620002 17266442 |
MESH:D051437 |
Renal Insufficiency |
|
Acrolein |
9.27 | 12732208 |
MESH:D051437 |
Renal Insufficiency |
|
Cisplatin |
9.27 | 15464296 |
MESH:D012120 |
Respiration Disorders |
|
Chlorine |
4.77 | 18579056 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
2-chloroethyl ethyl sulfide |
13.33 | 18257742 12210543 16292752 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Acetylcysteine |
13.33 | 12210543 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
pyrrolidine dithiocarbamic acid |
13.33 | 16129981 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.43 | 18990726 |
MESH:D012174 |
Retinitis Pigmentosa |
|
alpha-Tocopherol |
3.84 | 16849425 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
3.70 | 16283617 16116481 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Cisplatin |
9.26 | 14601052 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Etoposide |
9.26 | 14601052 |
MESH:D012559 |
Schizophrenia |
|
Copper |
3.02 | 16842975 |
MESH:D012595 |
Scleroderma, Systemic |
|
Cyclophosphamide |
4.42 | 16636934 |
MESH:D012640 |
Seizures |
|
Lithium |
6.13 | 19660546 |
MESH:D012640 |
Seizures |
|
Pilocarpine |
6.13 | 7750514 19660546 |
MESH:D012871 |
Skin Diseases |
|
Mustard Gas |
2.59 | 12880345 15451306 16961503 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
15.65 | 19755658 10029692 |
MESH:D012878 |
Skin Neoplasms |
|
gingerol |
15.65 | 19481070 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
15.65 | 19524636 18572023 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
15.65 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
15.65 | 16467112 |
MESH:D055752 |
Small Cell Lung Carcinoma |
|
Cisplatin |
4.90 | 15464296 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
10.10 | 16709447 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
10.10 | 16709447 |
OMIM:102530 |
SPERMATOGENIC FAILURE 6 |
|
Cyclophosphamide |
5.08 | 16517039 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
3.61 | 19457130 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.46 | 12854658 |
MESH:D013226 |
Status Epilepticus |
|
Lithium |
11.83 | 19570321 19430551 19951488 |
MESH:D013226 |
Status Epilepticus |
|
Pilocarpine |
11.83 | 11259499 19570321 19430551 15987249 19055492 19951488 15857427 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
4.30 | 20155912 2093021 |
MESH:D013274 |
Stomach Neoplasms |
|
Cisplatin |
4.30 | 17522103 15958060 18396642 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
4.30 | 18456281 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
4.30 | 17261132 |
MESH:D013276 |
Stomach Ulcer |
|
2-ethoxyethanol |
6.79 | 6499799 |
MESH:D013276 |
Stomach Ulcer |
|
Acetylcysteine |
6.79 | 17918041 |
MESH:D020521 |
Stroke |
|
Acrolein |
4.22 | 16269634 |
MESH:D015173 |
Supratentorial Neoplasms |
|
Cyclophosphamide |
4.63 | 12837982 |
MESH:D013733 |
Testicular Diseases |
|
2-ethoxyethanol |
9.63 | 10048760 6499806 10514026 |
MESH:D013733 |
Testicular Diseases |
|
methyl cellosolve |
9.63 | 6499806 |
MESH:D013736 |
Testicular Neoplasms |
|
Cisplatin |
4.23 | 15464296 17225452 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.22 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
2.79 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.46 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine |
10.31 | 16940797 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
10.31 | 7505956 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
10.31 | 16026305 17045167 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
3.41 | 16051514 |
MESH:D014202 |
Tremor |
|
Pilocarpine |
5.37 | 17594079 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
2.95 | 16040207 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
13.85 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Cisplatin |
13.85 | 12973940 17225452 15464296 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Cyclophosphamide |
13.85 | 14692829 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
13.85 | 11723127 16712894 16452187 17306315 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
13.85 | 8653321 16712894 17572228 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Cisplatin |
13.75 | 16803524 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
13.75 | 11813266 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
13.75 | 16129372 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
2.89 | 14692618 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
4.17 | 16752155 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
3.54 | 1336536 |
MESH:D014625 |
Vaginal Neoplasms |
|
Cisplatin |
4.19 | 15577323 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
3.99 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.15 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.15 | 14671159 15869587 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
3.65 | 16761959 |
MESH:D014839 |
Vomiting |
|
Cisplatin |
4.28 | 11897121 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
3.81 | 15886252 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.60 | 16287080 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.00 | 17120751 |